These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32270866)

  • 41. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer.
    Wei TT; Lin YT; Tang SP; Luo CK; Tsai CT; Shun CT; Chen CC
    Oncogene; 2020 Jan; 39(2):414-427. PubMed ID: 31477841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
    Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CircPDIA3/miR-449a/XBP1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the GSDME-C domain to induce chemoresistance of colorectal cancer.
    Lin J; Lyu Z; Feng H; Xie H; Peng J; Zhang W; Zheng J; Zheng J; Pan Z; Li Y
    Drug Resist Updat; 2024 Sep; 76():101097. PubMed ID: 38861804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo.
    Deng M; Yan P; Gong H; Li G; Wang J
    Mol Med; 2024 Jun; 30(1):95. PubMed ID: 38910244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
    Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
    Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
    Han J; Liu Z; Wang N; Pan W
    Oncol Rep; 2016 Jul; 36(1):542-50. PubMed ID: 27221209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
    Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
    Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
    Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
    Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
    J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer.
    Zhang Z; Feng L; Liu P; Duan W
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30279206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gegen Qinlian Decoction reverses oxaliplatin resistance in colorectal cancer by inhibiting YTHDF1-regulated m6A modification of GLS1.
    Lin X; Xu L; Gu M; Shao H; Yao L; Huang X
    Phytomedicine; 2024 Oct; 133():155906. PubMed ID: 39089089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1.
    Feng Y; Zhu J; Ou C; Deng Z; Chen M; Huang W; Li L
    Br J Cancer; 2014 Apr; 110(9):2300-9. PubMed ID: 24642628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long noncoding RNA ARSR is associated with a poor prognosis in patients with colorectal cancer.
    Li T; Jin X; Dong J; Deng H
    J Gene Med; 2020 Oct; 22(10):e3241. PubMed ID: 32558022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer.
    Izumi D; Toden S; Ureta E; Ishimoto T; Baba H; Goel A
    Cell Death Dis; 2019 Mar; 10(4):267. PubMed ID: 30890693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
    J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA MIR155HG induces M2 macrophage polarization and drug resistance of colorectal cancer cells by regulating ANXA2.
    Zhou L; Li J; Liao M; Zhang Q; Yang M
    Cancer Immunol Immunother; 2022 May; 71(5):1075-1091. PubMed ID: 34562123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.